Health

FluMist Home bursts onto the scene in August 2025 as the first self-administered nasal spray flu vaccine, greenlit by FDA...

Liquid biopsy's lancet-less leap vaults to $6.39B in 2025, a 14.8% CAGR rocket to $25.43B by 2035, per FMI's June...

AI's empathetic engines redefine mental health in 2025, with Wysa's chatbot—now insurer-backed by MassMutual for 2 million policyholders—delivering CBT and...

AI therapy apps deliver 70% anxiety alleviation through CBT cadences, JAMA Psychiatry November 5, 2025.Talkspace Q3 revenue $40.6 million +25%,...

Liquid biopsy detects 91% cancers from blood, 50+ types, NEJM November 6, 2025 trials.Multi-cancer early detection 80% stage I sensitivity,...

Nasal flu vaccine trials achieve 85% efficacy neutralizing influenza strains for high-risk groups, Health Affairs November 4.Injection-free immunity promises broader...

Nano vaccine trains immune system for 80% tumor remission in cancer trials, Nature Medicine November 21, 2025.RNA payloads personalize treatment,...

Liquid biopsy detects 50+ cancer types with 91% accuracy via blood draws, NEJM November 3 trials.Multi-cancer early detection 80% sensitivity...

AI therapy apps deliver 70% anxiety relief through CBT cadences, JAMA Psychiatry November 3 data.Talkspace Q3 revenue $40.6 million +25%,...

FluMist nasal spray vaccine approved for self-administration or caregiver use for 2025-26 season, first flu vaccine at home, FDA September...